Price loading...

The 2023-2028 Outlook for Pseudotumor Cerebri in China

Price data last checked 91 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
16 August 2022
Listed Since
24 August 2022

Similar Products You Might Like

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
97% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China

£495.00 12 Mar 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
97% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Peripheral Neuritis Treatments in China
97% match

The 2023-2028 Outlook for Peripheral Neuritis Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in China
96% match

The 2023-2028 Outlook for Prostaglandin Glaucoma Therapeutics in China

£495.00 09 Jan 2026
The 2023-2028 Outlook for Neurovascular Products in China
96% match

The 2023-2028 Outlook for Neurovascular Products in China

£495.00 09 Jan 2026
The 2023-2028 Outlook for External Neurostimulation in China
96% match

The 2023-2028 Outlook for External Neurostimulation in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Neurostimulation Devices in China
96% match

The 2023-2028 Outlook for Neurostimulation Devices in China

£495.00 18 Mar 2026
The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China
96% match

The 2023-2028 Outlook for Glioblastoma Multiforme Drugs in China

£495.00 10 Mar 2026
The 2023-2028 Outlook for Medical Imaging Phantoms in China
96% match

The 2023-2028 Outlook for Medical Imaging Phantoms in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China
96% match

The 2023-2028 Outlook for Neuroendocrine Tumor Treatments in China

£495.00 20 Jan 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in China
96% match

The 2023-2028 Outlook for Anti-Migraine Drugs in China

£495.00 13 Jan 2026
The 2023-2028 Outlook for Cushing's Syndrome Diagnostics and Treatments in China
96% match

The 2023-2028 Outlook for Cushing's Syndrome Diagnostics and Treatments in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China
96% match

The 2023-2028 Outlook for Proliferative Diabetic Retinopathy Treatments in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Cushing's Syndrome Diagnostics in China
96% match

The 2023-2028 Outlook for Cushing's Syndrome Diagnostics in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
96% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in China

£495.00 25 Jan 2026
The 2023-2028 Outlook for Epilepsy Monitoring Devices in China
96% match

The 2023-2028 Outlook for Epilepsy Monitoring Devices in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Insomnia Therapeutics in China
96% match

The 2023-2028 Outlook for Insomnia Therapeutics in China

£495.00 10 Mar 2026
The 2023-2028 Outlook for Amyloidosis Treatments in China
96% match

The 2023-2028 Outlook for Amyloidosis Treatments in China

£495.00 08 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China

£495.00 19 Apr 2026
The 2023-2028 Outlook for Insomnia in China
96% match

The 2023-2028 Outlook for Insomnia in China

£495.00 12 Jan 2026
The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China
96% match

The 2023-2028 Outlook for Diabetic Retinopathy Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Dry Eye Syndrome Treatments in China
96% match

The 2023-2028 Outlook for Dry Eye Syndrome Treatments in China

£495.00 23 Jan 2026
The 2023-2028 Outlook for Phycocyanin in China
95% match

The 2023-2028 Outlook for Phycocyanin in China

£495.00 28 Jan 2026
The 2023-2028 Outlook for Diabetic Neuropathy in China
95% match

The 2023-2028 Outlook for Diabetic Neuropathy in China

£495.00 13 Jan 2026